MF
Mary Kay Fenton
Chief Financial Officer

Mary Kay Fenton insider trades: Cullinan Therapeutics (CGEM) stock buys and sales

Chief Financial Officer, Cullinan Therapeutics Last trade Feb 20, 2026 34 Form 4 filings
$60K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2011
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mary reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 20, 2026CGEM↓ Sell$60K
Dec 5, 2016ACHN↑ Buy$10K
Dec 28, 2015ACHN↓ Sell$438K
Jan 23, 2015ACHN↓ Sell$210K
Jan 10, 2012ACHN↓ Sell$168K
Apr 6, 2011ACHN↓ Sell$32K
Mar 30, 2011ACHN↓ Sell$30K
Jan 13, 2011ACHN↓ Sell$44K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CGEM insiders

Open-market trades in the last 12 months

About Mary Kay Fenton's insider trades

Mary Kay Fenton is Chief Financial Officer at Cullinan Therapeutics (CGEM). Since Jan 13, 2011, Mary has reported 1 open-market purchase worth $10K and 7 sales worth $982K on SEC Form 4. In the last 12 months: 1 sale ($60K).

Their filings also include grants and awards (23 filings), option exercises (5 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CGEM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.